51
Participants
Start Date
July 31, 2013
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
23-valent pneumococcal polysaccharide vaccine
One standard adult dose of the 23-valent pneumococcal polysaccharide vaccine
13-valent pneumococcal conjugate vaccine
One dose of the 13-valent pneumococcal conjugate vaccine, PCV13, followed 8 weeks later by one dose of the 23-valent pneumococcal polysaccharide vaccine, PPV23.
The University of Toledo-Health Science Campus, Toledo
National Institute on Aging (NIA)
NIH
University of Toledo Health Science Campus
OTHER